clinical trials for glp 1 Could GLP-1 medications help slow cancer progression?⁣ ⁣ A new Cleveland Clinic study found those taking GLP-1s were less likely to develop stage IV disease in several cancer types, when compared to Glucagon-like peptide-1 receptor: mechanisms and

This prolonged half-life means that drug interaction effects on gastric emptying persist for the full dosing interval rather than tapering after 24 hours, unlike shorter-acting GLP-1 receptor agonists such as exenatide twice daily

Supplemental L-Carnitine is hard to absorb

Can J Cardiol 2023, 39: 17121727

Boxed warning for Wegovy : Wegovy carries an FDA-boxed warning for a potential risk of thyroid C-cell tumors

If SAH accumulates, homocysteine is poorly managed or sulfur-amino-acid substrate is inadequate, the liver may have less flexibility to maintain methylation while also supplying cysteine for glutathione and taurine

[PMID: 40085100] PubMed record related to this compound for laboratory literature review